GSE79027 L-13 3 v 6 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE79027_L-13_3_v_6_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE79027_L-13_3_v_6_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE79027_L-13_3_v_6_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE79027_L-13_3_v_6_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 1619

Gene

ITPR1 divergent transcript

Gene

uncharacterized LOC105372705

Gene

leucine rich repeat containing 37 member A15, pseudogene

Gene

NEFH pseudogene 1

Gene

uncharacterized LOC124906892

Gene

immunoglobulin heavy variable 1-69-2

Gene

long intergenic non-protein coding RNA 2526

Gene

cyclin G1 pseudogene 1

Gene

receptor transporter protein 5 (putative)

  • Gene

    long intergenic non-protein coding RNA 1619


  • Gene

    ITPR1 divergent transcript


  • Gene

    uncharacterized LOC105372705


  • Gene

    leucine rich repeat containing 37 member A15, pseudogene


  • Gene

    NEFH pseudogene 1


  • Gene

    uncharacterized LOC124906892


  • Gene

    immunoglobulin heavy variable 1-69-2


  • Gene

    long intergenic non-protein coding RNA 2526


  • Gene

    cyclin G1 pseudogene 1


  • Gene

    receptor transporter protein 5 (putative)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.